Jennifer Sexton

Director/CAS Custom Services

Bio

As part of CAS Custom Services, Jennifer designs individualized client solutions by leveraging CAS content, technology, and subject matter experts to solve complex client R&D and business challenges. Jen joined CAS Custom Services in 2020 after spending over a decade as a strategic account manager. Part of her former role included writing and delivering technical customer training for the CAS STN and CAS SciFinder® software platforms.

Jennifer holds a Master of Science degree in chemistry from the University of Notre Dame. She has a Bachelor of Science degree in chemistry and a Bachelor of Arts degree in psychology from Southwest Minnesota State University. She is a member of the Patent Information Users Group (PIUG) and the American Chemical Society (ACS).

Biotechnology
Discover how custom digital solutions can help companies build resilient and efficient biotech supply chains while accelerating innovation.
|Article
Read the CAS Insights article
Digital R&D
Discover how artificial intelligence in pharma can enhance drug repurposing by leveraging dark data, ensuring data diversity, and improving data quality.
|Article
Read the CAS Insights article
Digital R&D
Learn how emerging trends in AI are impacting CBRNE threat detection and mitigation.
|Article
Read the CAS Insights article
Digital R&D
Data-driven technologies play a pivotal role in swift analysis and quick response to chemical threats.
|Article
Read the CAS Insights article
Digital R&D
Learn how digital transformation is reducing waste and creating new revenue streams for companies as they repurpose waste byproducts.
|Article
Read the CAS Insights article
Digital R&D
Pharmaceutical manufacturers are investigating ways to cultivate insights from dark formulations data, turning once-hidden knowledge into drug discoveries.
|Article
Read the CAS Insights article
Digital R&D
As the drug repurposing market grows, pharmaceutical manufacturers are investigating ways to cultivate insights from dark formulations data, turning once hidden insights into drug repurposing innovations.
|Article
Read the CAS Insights article
Digital R&D
Digital initiatives are transforming the chemical industry, allowing for faster innovation and a sustainable future.
|Article
Read the CAS Insights article
Digital R&D
Strategies to unlock dark data in the pharmaceutical industry. Reveal data insights and accelerate innovation through digitization and knowledge management.
|Article
Read the CAS Insights article
Digital R&D
Digital initiatives are transforming the pharmaceutical industry, allowing for faster drug development and expanded treatment options.
|Article
Read the CAS Insights article
Digital R&D
Research and development teams amass huge quantities of complex data which, if exploited correctly, can be a useful information source to improve decision-making and drive innovation.
|Article
Read the CAS Insights article